All > Uti > Oa

Attune TruMatch (TM) Patient-Specific Instrumentation for Obesity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Obesity+1 MoreAttune TruMatch (TM) Patient-Specific Instrumentation - Device
Eligibility
20 - 70
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the clinical outcomes and economic viability of using patient-specific instrumentation for total knee arthroplasty in obese patients.

Eligible Conditions
  • Obesity
  • Osteoarthritis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Eflapegrastim
1
(2R,6R)-Hydroxynorketamine hydrochloride
1
Light therapy A via the Re-Timer®

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 1 year, 5 years and 10 years post-operatively

Year 10
Incremental cost-utility ratio
Year 10
Assessment of Possible Change in Peri-operative metrics
Year 1
Assessment of Possible Change in Radiographic Alignment
Year 1
Patient-completed questionnaires

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
Eflapegrastim
1
(2R,6R)-Hydroxynorketamine hydrochloride
1
Light therapy A via the Re-Timer®

Trial Design

2 Treatment Groups

Total Knee Replacement
1 of 2
Total Knee Arthroplasty with PSI
1 of 2

Active Control

Experimental Treatment

194 Total Participants · 2 Treatment Groups

Primary Treatment: Attune TruMatch (TM) Patient-Specific Instrumentation · No Placebo Group · N/A

Total Knee Arthroplasty with PSI
Device
Experimental Group · 1 Intervention: Attune TruMatch (TM) Patient-Specific Instrumentation · Intervention Types: Device
Total Knee ReplacementNoIntervention Group · 1 Intervention: Total Knee Replacement · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year, 5 years and 10 years post-operatively

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
614 Previous Clinical Trials
401,977 Total Patients Enrolled
7 Trials studying Obesity
1,072 Patients Enrolled for Obesity
DePuy OrthopaedicsIndustry Sponsor
77 Previous Clinical Trials
26,056 Total Patients Enrolled
Johnson & Johnson Medical CompaniesIndustry Sponsor
5 Previous Clinical Trials
465 Total Patients Enrolled
Edward M Vasarhelyi, MDPrincipal InvestigatorLondon Health Sciences Centre
1 Previous Clinical Trials
50 Total Patients Enrolled

Eligibility Criteria

Age 20 - 70 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
Patients who are between the ages of 19 and 70 are eligible to receive the vaccine.
were included patients who have a body mass index that is greater than 30 and less than or equal to 50 were chosen to be a part of this study.
Symptomatic knee osteoarthritis is most appropriately treated with a total knee arthroplasty.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top